Abstract:OBJECTIVE:To study whether the expression level of cyclooxygenase-2 (COX-2) is correlated with the proliferation and apoptosis of cancer cells and to study whether the RNA interference technique can be used in anti-cancer gene therapy.METHODS:WBH1, a eukaryotic expression plasmid of shRNA targeting on COX-2, was constructed. Human gastric cancer cells of the line SGC-7901 were cultured and divided into 3 groups: to be transfected with WBH1 or negative control plasmid HK, or used as un-transfected control group. RT-PCR and Western blotting were used to detect the expression of COX-2 mRNA and protein. MTT method was used to detect the proliferation of the cells. The apoptosis of the cells was determined by flow cytometry. Fifteen nude mice were randomly divided into 3 equal groups: 10 to be inoculated subcutaneously with WBH1 plasmid transfected SGC-7901 cells (inhibition group) or negative control plasmid HK transfected SGC-7901 cells, and 5 were used as un-transfected controls. The mice were observed for 4 weeks to observe the survival and the tumorigenesis. Then the mice were killed to take out the tumors. The tumorigenic rate and tumor inhibition rate were evaluated.RESULTS:The proliferation of the SGC-7091 cells transfected with WHB1 plasmid did not changed significantly 24 and 48 hours after the transfection, however, decreased significantly 96 hours and 1 week after (both P < 0.01). The apoptotic rate of the SGC-7091 cells transfected with WHB1 plasmid was 52.28% +/- 17.91%, significantly higher than that of the cells transfected with the control plasmid HK (0.54% +/- 0.16%) and that of the un-transfected cells (0.52% +/- 0.27%, both P = 0.009) without a significant difference between the latter 2 groups (P = 0.998). Four weeks after inoculation the tumorigenic rate was 100% in both the un-transfected control mice and the mice inoculated with negative plasmid HK transfected SGC-7901 cells. There was no significant difference in tumor size between these 2 groups (P = 0.965). The tumorigenic rate of the mice in the inhibition group was 0.4 with an inhibition rate of 89.8%. The tumor weight of the inhibition group was 0.050 g +/- 0.003 g, significantly lighter than those of the control group and the group inoculated with negative plasmid transfected SGC cells (0.490 g +/- 0.017 g and 0.490 g +/- 0.013 g respectively, both P < 0.01).CONCLUSION:Construction of a eukaryotic expression vector expressing the specific shRNA targeting on COX-2, closely related to the proliferation and apoptosis of tumor cells, and transfection of it into the tumor cells helps inhibit the expression of COX-1, thus inhibiting the growth and proliferation of the tumor cells.

Lentivirus-mediated Sirna Targeting Cyclooxygenase-2 Gene Inhibits Human Laryngocarcinoma Cells Proliferation and Invasion

Inhibition of malignant phenotypes of human laryngeal cancer cells by anti sense nucleic acid of cyclooxygenase-2

siRNA-mediated silencing of BC047440 gene inhibits proliferation of human HepG2 cell

BC047440 Gene Silencing Inhibits the Proliferation of HepG2 Cells

Small interfering RNA targeting LASS2 gene enhances invasion capacity of hepatocellular carcinoma cells

Knockdown of Cyclooxygenase-2 Leads to Growth Inhibition and Cell Cycle Arrest in Hepatocellular Carcinoma Cells.

shRNA-targeted Cyclooxygenase (COX)-2 inhibits proliferation, reduces invasion and enhances chemosensitivity in laryngeal carcinoma cells

[Effects of Cyclooxygenase-2 Antisense Vector on Proliferation and Sensitivity to Cisplatin of H1299 Cells].

[Effects of Inhibition of Cyclooxygenase-2 by RNA Interference on Proliferation and Apoptosis of Human Gastric Cancer Cells: an Experimental Study with Human Gastric Cancer Cells and Mice].

Effect of COX-2 Gene Silence on Proliferation and Invasion Ability of OS-RC-2 Cell

Effects of Cyclooxygenase-2 Antisense Vector on Proliferation of Human Cholangiocarcinoma Cells

STUDY ON THE EXPRESSION OF CYCLOOXYGENASE-2 IN HEPATOCELLULAR CARCINOMA CELL LINES AND ON THE GROWTH INHIBITION EFFECT OF NS-398

Effects of Cyclooxygenase-2 SiRNA-mediated Gene Silencing on Proliferation and Apoptosis of Human Colon Cancer Cells

Effects of COX-2 Gene Expression Inhibited by Shrna on Growth of Hepatocellular Carcinoma HepG_2 Cells

Effects of Silencing Cyclooxygenase-2 Expression Via RNA Interference on the Tumorigenicity of the SMMC-7721 Human Hepatocarcinoma Cell Line.

[Inhibitory Effect of Lentiviral Vectors Expressing Small Interfering RNA Targeting Survivin Gene on Hep-2 Cell Growth in Vitro and in Nude Mice].

Effect of Small Interfering RNA Targeting CD47 Gene Mediated by Lentivirus Vectors on Proliferation and Apoptosis of Human Laryngocarcinoma Hep-2 Cells

Effects of the Inhibition of Cyclooxygenase-2 on Human Esophageal Cancer Cells: Inhibition of Cell Proliferation and Induction of Apoptosis

Inhibition of Human Hepatocellular Carcinoma Tumor Angiogenesis by Sirna Silencing of VEGF Via Hepatic Artery Perfusion.

Inhibitory Effects of Cyclooxygenase-2 Inhibited by Shrna on the Growth and Angiogenesis of Human Liver Cancer Cell Subcutaneous Xenograft Tumors in Nude Mice

Promotive effect of cyclooxygenase-2 gene inhibited by shRNA on the tumor cells apoptosis of subcutaneous xenograft human liver cancers in nude mice